Guo Meng
Director/Miembro de la Junta en SSY GROUP LIMITED .
Fortuna: 12 M $ al 30/04/2024
Perfil
Guo Meng is currently an Executive Director & Deputy General Manager at SSY Group Ltd., a Director at New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd., and a Director at Hebei Guolong Pharmaceutical Co., Ltd.
Previously, Mr. Meng served as the Executive President & Director at Shijiazhuang No.
4 Pharmaceutical Co., Ltd.
Mr. Meng's education includes an undergraduate degree from Lanzhou University and a graduate degree from Beijing University of Technology.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
SSY GROUP LIMITED
0.67% | 30/06/2023 | 20 000 000 ( 0.67% ) | 12 M $ | 30/04/2024 |
Cargos activos de Guo Meng
Empresas | Cargo | Inicio |
---|---|---|
SSY GROUP LIMITED | Director/Miembro de la Junta | 27/08/2021 |
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd.
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. Financial ConglomeratesFinance Part of SSY Group Ltd., New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. operates as an investment holding Samoan company. The private company is based in Chaoyan, Samoa. New Orient Investments Pharmaceutical Holding (Hong Kong was acquired by SSY Group Ltd. from CMP Group Ltd. (Samoa) on June 29, 2007 for $91.31 million. | Director/Miembro de la Junta | - |
Hebei Guolong Pharmaceutical Co., Ltd. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Guo Meng.
Empresas | Cargo | Fin |
---|---|---|
Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shijiazhuang No.4 Pharmaceutical Co., Ltd. is a pharmceutical company in China. It offers medicines in forms of infusions, capsules, granules, tablets & oral liquids among others. The company was founded in 1948 and is headquartered in Hebei, CN. | Presidente | - |
Formación de Guo Meng.
Lanzhou University | Undergraduate Degree |
Beijing University of Technology | Graduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
SSY GROUP LIMITED | Health Technology |
Empresas privadas | 3 |
---|---|
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd.
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. Financial ConglomeratesFinance Part of SSY Group Ltd., New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. operates as an investment holding Samoan company. The private company is based in Chaoyan, Samoa. New Orient Investments Pharmaceutical Holding (Hong Kong was acquired by SSY Group Ltd. from CMP Group Ltd. (Samoa) on June 29, 2007 for $91.31 million. | Finance |
Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shijiazhuang No.4 Pharmaceutical Co., Ltd. is a pharmceutical company in China. It offers medicines in forms of infusions, capsules, granules, tablets & oral liquids among others. The company was founded in 1948 and is headquartered in Hebei, CN. | Health Technology |
Hebei Guolong Pharmaceutical Co., Ltd. |
- Bolsa de valores
- Insiders
- Guo Meng